drugset / Trial / NCT01824225
Study of PRN and Every 2months Intravitreal Aflibercept for Age Related Macular Degeneration
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Evaluate a treatment result of every two months versus as needed (PRN) after 3 initial monthly intravitreal aflibercept for the Japanese age related macular degeneration.
Timeline
- Start
- 2013-03
- Primary completion
- 2014-03
- Completion
- 2015-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aflibercept | Protein / enzyme biologic | — | Intravitreal |